wakl, I've copied your idea. A very wise one. I've emailed and asked for any information about mass production, future license agreements, time frames for patent-pending products, future pipeline products and plans for commercialization for products in Q1. As I remember, Baum had come out in a few PR's and stated that they plan on commercialization in Q1 for their first product. I believe we are approaching the end of Q1 with no further word. Sitting tight with a flatline PPS is ok for now, but the tough part is still in front of Shrink. Plan development, marketing interest, developing a stronger investor base, and gaining industry support and parternships is a tall order. Sitting tight won't work for another year without an erosian in investor interest, financial support and market consideration (IMO). Any thoughts?
Speed
